TransCode Therapeutics (RNAZ)
(Delayed Data from NSDQ)
$1.45 USD
-0.49 (-25.26%)
Updated May 29, 2024 04:00 PM ET
Pre-Market: $1.56 +0.11 (7.59%) 9:26 AM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
06/03/2024
Time: -- |
3/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, TransCode Therapeutics (RNAZ) reported earnings of -$67.20 per share, missing the Zacks Consensus Estimate of -$60.00 per share. This reflects a negative earnings surprise of 12.00%. Look out for RNAZ's next earnings release expected on June 03, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year increase of 99.73%.
Earnings History
Price & Consensus
Zacks News for RNAZ
TransCode Therapeutics Inc. (RNAZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
RNAZ: What are Zacks experts saying now?
Zacks Private Portfolio Services